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Background: Research on the factors associated with dialysis withdrawal in chronic dialysis 
patients has been limited. Authors and clinicians have used different definitions for dialysis 
withdrawal, resulting in inconsistent findings. This thesis explored the factors associated with 
dialysis withdrawal defined as “patient refused further treatment or voluntary withdrawal from 
the dialysis program” in chronic dialysis patients.   
Methods: This retrospective study extracted patient information from the electronic renal patient 
management system Nephrocare™, and ClinicalConnect™ at the Grand River Hospital. A total 
of (N=723) patients who initiated chronic renal dialysis therapy (>30 days of duration) in renal 
dialysis program at Grand River Hospital (GRH), Ontario, during the period from 1st January, 
2012 to 30th September, 2017 were consecutively included in the study. Patients with acute 
dialysis or patients receiving dialysis before the start of the study were excluded. Age, sex, 
modality, comorbidities such as diabetes, cardiac disease, hypertension, vascular disease, lung 
disease, malignancy, dementia, depression and bipolar disorder and aetiology of kidney disease 
were selected as hypothesis variables and duration of dialysis was the controlled variable in this 
study.  
Results: The mean age of the sample was 64.86 years (±14.89) with 62.8% (n=454) males. The 
most common cause of renal disease was diabetes (33.6%) and the most common comorbidity 
was hypertension (94.5%). The mean duration of dialysis was 544.80 days (±486.83) days. The 




most common reason. The final logistic regression model showed that cardiac disease, [= 
0.6530; p=0.016], hypertension [= 1.7421; p=0.019], dementia [=1.1125; p=0.008] and 
age [=0.0342; p=0.002] were significantly associated with dialysis withdrawal, with 
significant influence of duration of dialysis [=-0.000841; p=0.0092] as a confounder on 
the above relationship.  
Conclusion: The study showed age, cardiac disease, hypertension and dementia are significant 
predictors related to dialysis withdrawal in chronic dialysis population. The findings may help in 
identifying patients who are susceptible to dialysis withdrawal at the start of dialysis. Future 
researchers and nephrologists should design and conduct intervention studies focusing on 
strategies controlling the severity of comorbidities (cardiac disease and hypertension), regular 
assessment and monitoring of the progression of dementia, and other dialysis program changes to 
decrease dialysis withdrawal rates in chronic dialysis patients. 
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Chapter 1 Introduction and Overview 
Chronic kidney disease (CKD) describes gradual loss of renal functions over a period of 
months or years and is classified into five stages, based on the measurement of estimated 
glomerular filtration rate (eGFR) (1, 2). The End Stage Renal Disease (ESRD) or CKD stage 5 
represents the severe form of renal function, characterized by an eGFR of <15 mL/min/1.73m2 
and require maintenance dialysis or renal transplantation (1, 2). The prevalence of both CKD and 
dialysis is increasing globally, mainly because of long survival rates within this population. 
Canada has the third highest ESRD incident and prevalence rate after the US and Japan (3-7). 
The incidence of chronic dialysis in Ontario since 2010 is at a stable rate of 3.3% each year.  In 
2015, around 15,529 patients have advanced kidney disease, with 11,118 patients receiving 
chronic dialysis in Ontario1. There has been a slight increase in dialysis population from 22.3% 
to 24.8%, from 2009 to 2015. In 2015, 75% of patients were receiving in-facility dialysis, 19% 
were receiving peritoneal dialysis, and 6% were receiving home hemodialysis (8). 
Despite the importance of dialysis for ESRD patients, previous studies have shown wide 
range in dialysis withdrawal (DW) rate ranging from 8% to 31% (9-12). Dialysis attrition, 
discontinuation or withholding, is one of the leading causes (12-26%) of death in ESRD patients 
in the US and Canada (13). Considering the need of dialysis in ESRD patients and a high 
                                                          
1 Ontario Renal Network (ORN). CKD System Atlas, 
http://www.renalnetwork.on.ca/cms/one.aspx?objectId=353745&contextId=256223#.WzVf_dJK





prevalence of dialysis withdrawal along with the associated morbidity and mortality, few authors 
have explored the factors associated with dialysis withdrawal.   
Gessert et al. (2013) have found a significantly higher dialysis withdrawal rate in women 
vs men (26.3% vs. 23.0%); older age vs younger age (29.83% vs.18.14%) and white race vs 
black race (29.5% vs. 14.7%) (36). Factors such as diabetes-induced ESRD and renovascular 
disease were associated with increased rate of withdrawal (HR=1.58 and HR=1.26, respectively 
(11). Additionally, having a low BMI (Body Mass Index) <18.5 kg/m (HR=1.37), is associated 
with increased rates of withdrawal (11). Type of dialysis: PD (Peritoneal dialysis) and HD 
(Hemodialysis), comorbid conditions such as diabetes and cardiac diseases and laboratory values 
such as albumin, phosphate and hemoglobin are associated with dialysis withdrawal (10-13, 15, 
17). However, few studies have also shown insignificant association between gender, BMI, 
socioeconomic predictors, comorbidities, aetiology of renal disease, albumin and creatinine, and 
type and duration of dialysis with dialysis withdrawal (10-17). 
The scarcity of literature and the overall inconsistent and inconclusive findings warrants 
an in-depth exploration of the relationship to investigate predictors that might influence the rate 
of dialysis withdrawal and identify gaps in the literature, (with regards to the factors associated 
with dialysis withdrawal), in which original research is needed. In addition to identifying gaps in 
the literature, the proposed review will also help in identifying the possible reasons for the 
differences in findings by collating, summarizing, analyzing and synthesizing the research 
findings by drawing conclusions from the existing literature.  
This thesis consists of the present chapter and six subsequent chapters. The present 




with dialysis withdrawal. The next chapter presents literature review on the factors associated 
with withdrawal from the chronic dialysis. Chapter 3 provides a rationale to conduct an original 
research, and provide specific aims and objectives of the study. Chapter 4 includes a detailed 
description of the methods. Chapter 5 provides descriptive and regression results. Chapter 6 
synthesizes the findings in relation to existing literature, identifies study strengths, limitations 
and advancement of knowledge transferrable into practice. The last chapter of this thesis 





Chapter 2 Literature Review 
2.1 End-Stage Renal Disease (ESRD) and Dialysis 
End Stage Renal Disease (ESRD) is the irreversible deterioration of kidney function and 
is defined by a glomerular filtration rate (GFR) of <15ml/min (normal is >60 ml/min) (1, 2). 
ESRD has multifactorial aetiology as a complication of diabetes mellitus, hypertension, 
autoimmune diseases and congenital abnormalities (19). There are nearly 700,000, 120,000 and 
135,000 people with CKD stage 5 in the US, UK and Europe, respectively. The prevalence of 
ESRD in Saudi Arabia is 5.7% and 6% in Australia. Furthermore, from 2006-2012, Canada has 
the third highest ESRD incident rate and prevalence rate after the US and Japan (3-7).  
The treatment of ESRD is maintenance dialysis or transplant, though in a small 
number of patients’ life style changes and drug treatment may help (1, 2, 20). Dialysis is a 
treatment modality in which wastes and toxins are removed from the blood and is a treatment 
of choice following a significant damage to the kidneys (21-27). The first successful dialysis 
was initiated by Dr. Willem Kolff in a 67-year-old female in 1943. The first outpatient 
hemodialysis was performed by Belding Scribner in 1960, as a conventional (3 times a week) 
dialysis therapy. Later, Scribner developed a portable dialyzer, leading to 40% of the patients 
performing home dialysis by 1970 (21-27). 
Currently, many dialysis treatment alternatives are available in ESRD patients as 
shown in Table 1. These modalities are dependent on whether dialysis performed at home or 




duration (acute or chronic) of dialysis. Hemodialysis (HD)is a dialysis modality in which a 
filter and dialysis machine is attached to the patient via catheter inserted in a major vein, 
usually in the patient's subclavian to remove waste and toxins from the blood stream and 
correct the electrolyte imbalance (8, 21-24, 28). Peritoneal dialysis (PD) is a dialysis 
treatment in which the cleansing fluid is inserted into the peritoneal cavity via catheter, the 
fluid filters the waste products and toxins from the blood, after some time the fluid along with 
the waste is removed via catheter and is discarded (8, 28, 29).  
Table 1 Dialysis Treatment Modalities Available in End-Stage Renal Disease (ESRD) 
Population  
Modality Definition 
Hemodialysis (HD) Dialysis through blood 
Peritoneal dialysis (PD) Dialysis through peritoneal fluid  
Acute or short term or 
transient dialysis 
Dialysis <30 days 
Chronic or long term 
dialysis2 
Dialysis ≥30 days 
 
Dialysis can be conventional the most common form), followed by daily and/or 
nocturnal (8, 26, 27). The type of peritoneal dialysis includes: Continuous Ambulatory 
                                                          






Peritoneal Dialysis (CAPD) in which patient’s abdominal cavity fluid is exchanged around 4 
times/24 hours via an implanted peritoneal catheter and in Automated Peritoneal Dialysis 
(APD) or CCPD (Continuous Cycling PD), fluid exchange occurs at night which may be 
supplemented by additional day time fluid exchanges (8, 28, 29). Dialysis can also be 
classified as short-term transient or acute dialysis (<30 days) and long term or chronic dialysis 
(≥30 days) (8, 28, 29).  
The prevalence of maintenance dialysis ranged from the lowest in China around 79 
pmp (per million population) to the highest in Japan (2385 pmp). The incidence rates of 
maintenance dialysis ranged from 91 pmp in UK to 349 pmp in the US (30). The renal 
replacement therapy (RRT) is higher in Ontario than the national average of Canada; while 
the prevalence of CKD is the same. An estimated 11,200 patients in Ontario are on dialysis 
(8). The most prevalent is hemodialysis (76.3%), followed by peritoneal dialysis (18.1%) and 
home hemodialysis (5.6%) (8). 
2.2 Factors Associated With Dialysis Withdrawal (DW) 
Despite the availability of chronic dialysis programs, the morbidity and mortality in 
ESRD patients, remains high. There are many factors associated with survival models in ESRD 
patients including modifiable factors such as patient health status, BMI, serum urea, albumin and 
hemoglobin and non-modifiable factors such as age, gender and race and comorbidities (31-35). 
Dialysis attrition, discontinuation or withholding, is one of the leading causes (12-26%) of death 
in ESRD patients in the US and Canada (13, 14). However, in European countries, dialysis 
withdrawal, withholding or discontinuation is low, only 2–7% of all causes of deaths (13). Few 




comorbidities, cause of ESRD; serum albumin and phosphorus, and duration and type of dialysis 
modality with dialysis withdrawal (9-13). Religion and cultural beliefs and ethnicity can also 
influence the withdrawal from dialysis (14). 
2.2.1 Demographics 
The relationship between demographic factors such as age, gender, race/ethnicity, 
residence, education, employment and marital status and dialysis withdrawal have been explored 
by few researchers in different geographical locations (9-11, 13, 15, 17, 18). Older age is 
associated with higher rate of dialysis withdrawal. Discontinuation of dialysis was more frequent 
in ≥ 70 years old patients versus < 70 years old (29.83% vs. 18.14%, p < 0.001) (36). Ellwood et 
al. (2013) found higher rates of withdrawal in patients older than 75 years old than their younger 
counterpart, and the increasing of age was significantly associated with DW (HR, 1.81; 95% CI, 
1.75–1.88) (11). Findlay et al. (2016) also found the same association of older age with dialysis 
withdrawal (37). Older aged patients have multiple medical problems and comorbidities that 
worsens with increase duration of dialysis, with a rapid alteration in physical and mental health, 
leading to dialysis withdrawal and discontinuation of treatment (11, 13, 38). 
Dialysis withdrawal varies with race and ethnicity, patient-based dialysis discontinuation 
was more frequent whites than blacks (29.5% vs. 14.7%, p < 0.001) or patients of other races 
(29.5% vs. 19.2%, p < 0.001) (36). Similarly, other authors have reported a higher rate of DW in 
white persons than African Americans and Asians (36, 39-43). This difference in dialysis 
withdrawal between different ethnicities is unclear, though highlights the role of social and 
cultural values in decision to withdraw or continue dialysis (10, 11). One of the reasons for the 




societal and cultural beliefs play an influencing role in deciding continuation or withdrawal of 
dialysis (10, 44, 45). The difference may also be more pronounced in a geographical setting with 
historical issues, such as in the US, where non-white race lacks trust in health care and 
physicians’ advice of dialysis withholding, due to inequality in health care, leading to 
continuation of dialysis as compared to whites (46). 
The association between dialysis withdrawal and gender is inconsistent and inconclusive. 
Gessert et. al. has shown that women are more likely to withdraw from dialysis than men, a 
higher DW rate in women vs men (26.3% vs. 23.0%, p < 0.001) (36). However, Seshasai et al. 
(2016) found males had a high withdrawal rate than females (9). The difference in studies may 
be related to gender inequality in treatment and management decision-making (10, 47). Gender 
bias in clinical-decision making is still prevalent in many under developed regions and low socio 
economic areas (10, 47). In some religions, cultures, societies, race and ethnicities, women are 
less privileged than men and have less access to expensive, quality health care, such as renal 
dialysis and transplantation (10, 47). 
The area of residence is also associated with dialysis withdrawal. Residents of small 
towns and villages have a higher rate of DW compared to those living in larger towns and cities 
(26.9% vs. 24.3%, p < 0.001) (10, 36). Authors have also shown that marriage status such as 
divorced or widowed and/or living in nursing homes is one of the predictors of DW (18, 48). 
However, Birmele et al. (2004) found that living alone, or with family or spouse is not a 
significant predictor of withdrawal (13). However, its worth noting that this study has a small 
subsample size (n=40) in DW group. Similarly, authors have shown that single, married, or 
divorced was not associated with dialysis withdrawal, though the association was significant in 




significantly associated in adjusted and non-adjusted models, and less than 12 years of education 
was an insignificant factor in both the models (18). The same study also found employment is a 
significant factor in dialysis withdrawal (18). The authors pointed out that patients of lower socio 
economic status such as less education and lower employment status are underprivileged 
members of the society who may lack access to good quality health care, communication, 
transport and community support system that facilitates them to continue the treatment which 
requires frequent visitation (3-4 times for conventional HD) to the dialysis centre (18, 48).  
2.2.2 Renal Disease 
The primary aetiology of renal disease is also associated with DW. Patients with renal 
failure caused by hypertensive renal disease have higher risk of DW than those with 
glomerulonephritis. Ellwood et al. (2013) found diabetes-induced ESRD and renovascular 
disease were associated with increased rate of DW (HR= 1.58 [95% CI 1.37– 1.82] and HR= 
1.26 [95% CI 1.06–1.49], respectively) (11). However, Birmele et al. (2004) found causes of 
CKD such as glomerulopathy, diabetic, interstitial and vascular nephropathy and polycystic 
kidney disease were not associated with DW (13). Furthermore, another study showed that type 1 
diabetes was associated with DW but type 2 diabetes and glomerulonephritis, amyloidosis, 
polycystic kidney disease and nephrosclerosis were not associated (49). These insignificant 
findings may be attributed to the small subsample of DW patients, as many of the subgroup of 
aforementioned renal diseases have only 1 to 5 patients (49). 
2.2.3 Health Behaviour 
Behaviour risk factors such as smoking, substance abuse and alcohol dependence, and 




associated with DW in hemodialysis group (HR=1.34 [95% CI 1.01-1.78]) (9). Similarly, Fissell 
et al. (2005) showed that patients who have alcohol dependence have higher odds of DW in 
unadjusted analysis, but the same risk factor was insignificant in the adjusted analysis. (18).  
Patients having a low BMI may have malnutrition and poor health status, increasing the 
odds of DW, due to the worsening of comorbidities and physical deteriorating condition 
associated with continuation of dialysis. Having a BMI higher than 18.5 kg/m (HR= 1.37[95% 
CI 1.16–1.61]) is associated with increased rates of DW (11).  However, categorization of BMI 
into underweight (<18.5), healthy (18.5-25), overweight (>25-30) and obese (>30) were not 
associated with DW of PD patients (14). The difference in the relationship between DW and 
BMI may be attributed to type of dialysis with withdrawal from PD less dependent on BMI as 
compared to HD.  
2.2.4 Laboratory Indicators 
Laboratory values such as serum albumin, creatinine, phosphorus/phosphate and 
hemoglobin are associated with DW. Hazama et al. (2014) found hemoglobin and albumin were 
associated with PD withdrawal, but creatinine and uric acid were not associated (15). Excretion 
of peritoneal albumin is significantly associated with cardiac diseases, resulting in dialysis 
withdrawal (50-52). Another study showed that serum creatinine and phosphate were associated 
with withdrawal, but serum potassium was not associated (17).  
The relationship between serum phosphate and dialysis withdrawal, highlights the 
importance of dietary control of phosphorus and use of phosphate-binder medication during 
dialysis, as these preventive measures decreases DW (17). Serum creatinine was associated with 





Authors have found that comorbidities such as dementia, diabetes, cerebrovascular 
diseases and malignancy are associated with dialysis withdrawal. Addition of comorbidities and 
their combination are also positively associated with DW (10). Patients with chronic conditions 
such as cancer, dementia, diabetes, hypertension and cachexia are more likely to withdraw than 
those with acute conditions such as stroke, infection, angina and heart failure disease (13). 
Chronic diseases gradually deteriorate a patient’s health status, leading to complications that 
could cause a cascade of health issues, increase the burden of disease, resulting in the patient’s 
withdrawal from dialysis treatment (42).  
Patients with poor health status at the start of dialysis have higher risk of dialysis 
withdrawal. In addition to a patient’ physical health, quality of life measures, especially pain, is 
found to be a significant predictor to DW.  A study has shown a higher withdrawal rate in 
patients suffering from chronic pain (54). Davison (2012) found that almost half of patients 
(50%) have significant pain at the time of discontinuation of dialysis (55). However, it is difficult 
to distinguish and understand the biologic plausibility between pain and depression in relation to 
dialysis withdrawal (17, 54). Since patients with comorbidities have higher risk of depression, 
despair, loss of positivism and hopelessness than patients without comorbidities (17, 54), a 
patient’s decision to discontinue the dialysis treatment may be due to depression and not with 
chronic pain/discomfort (17, 54).  
2.2.6 Dialysis Modality and Duration 
The relationship between dialysis modality such as hemodialysis (HD), home 




a higher rate of DW in HD patients than that of PD patients (12).  Chan et al. (2012) found a 
negative effect of peritoneal dialysis on dialysis withdrawal in both unadjusted and adjusted 
models (10). This difference in findings between studies may be explained by the general health 
status, disease burden and comorbidities at the start of dialysis (13). Peritoneal dialysis is mostly 
performed at home in patients that have more self control and family support to be able to 
perform routine dialysis (13). This self control improves patient’s confidence, active 
participation in daily activities, and mental health and wellbeing, perhaps reducing chances of 
dialysis withdrawal, as compared to in-hospital hemodialysis (10, 13). This finding may be 
attributed to selection bias and confounding. Patients having high disease burden and 
comorbidities have higher odds of undergoing HD than PD (13).  
The poor mental health status is associated with dialysis withdrawal; and, HD patients 
have higher rate of dialysis withdrawal than PD (54). However, few authors found insignificant 
effect of type of dialysis on dialysis withdrawal (13). Ellwood et al. (2013) found patients 
undergoing hemodialysis have a higher rate of withdrawal as compared to patients in non-
withdrawal group, but type of dialysis modality (HD vs PD) was insignificantly associated with 
DW (11). 
The relationship between duration of dialysis and DW is inconclusive, as McDade-
Montez (2006) found insignificant association for duration of dialysis (in month) between 
withdrawal and non-withdrawal group (17). This finding may be attributed to small subsample of 
dialysis withdrawal group (n=40). Another study showed that duration of dialysis in years was 
not significantly different between patient who withdrew and continue dialysis (13). Many of the 
dialysis patients have short survival, and exploration of duration of dialysis in months or number 




2.3 Review Summary and Research Gap 
The literature review revealed a scarcity of research on the factors associated with 
dialysis withdrawal. The findings of the studies are inconsistent and inconclusive. Authors 
have shown differences in dialysis attrition rates and factors associated with dialysis 
withdrawal, and the direction and strength of the association for similar factors is also 
inconsistent. This difference may be due to several reasons. The definition of dialysis 
withdrawal is not consistent, as authors have used this concept in terms of discontinuation, 
withholding, death, withdrawal, treatment refusal/ceased, or technique failure (8-11, 14, 17).  
The discontinuation was defined as no dialysis treatment within sixty-day period (9). 
Withdrawal was defined as either withdrawal from treatment, suicide, and accidental death or 
patient refusal for further treatment or treatment ceased (10). Withholding therapy was 
defined as stopping or not to start or increase a life sustaining intervention. Few studies have 
also provided exclusions while defining dialysis withdrawal as excluding patients with return 
of kidney function (11). Technique failure was defined as discontinuation of peritoneal 
dialysis for > 6 weeks (17). 
Dialysis withdrawal rate and associated factors are dependent on the type of modality 
such as HD or PD (9, 12, 14, 15, 17, 18, 21). Many of the studies have selected either PD or 
HD patients but not both, making comparisons and inferences difficult to interpret (9, 12, 17).  
Patients with comorbidities, such as diabetes, and heart diseases and other chronic 
debilitating diseases are associated with dialysis withdrawal (10). Poor general health 




resulting in more likelihood of dialysis withdrawal than with patients of otherwise good 
health condition (13, 20, 21). However, few authors have also shown insignificant effect of 
diabetes, vascular disease, stroke, cancer, arrhythmia and lung disease. This difference may 
be explained by number of diseases or comorbidities included in the study and duration, 
severity and type (10, 23). 
Old age, females, whites and having chronic diseases are associated with dialysis 
withdrawal (10, 11, 20, 21). However, few studies showed that demographic factors are not 
associated with dialysis withdrawal (13, 18). The geographical setting of the study has also 
accounted for these differences, as race/ethnicities, preferences and whether to withdraw 

















Chapter 3  
Study Rationale and Research Objectives 
3.1 Rationale 
Considering the scarcity of literature, a high prevalence of dialysis withdrawal and 
inconsistent results warrant further exploration of the topic by conducting an original study to 
identify the factors that can influence a patient’s decision to withdraw from dialysis (10-17). The 
proposed study will provide better understanding of the factors and their association in relation to 
dialysis withdrawal and if the dialysis modality influences this relationship. This understanding 
will help the care provider and patients alike to improve the clinical decision-making by 
identifying patients who are at risk of withdrawal from the treatment.  Interventions to influence 
the modifiable risk factor can be offered to help patients to achieve a better survival outcome.   
3.2 Aims and Objectives 
The purpose of the study is to perform a retrospective analysis of chronic dialysis patients 
and their corresponding treatment modalities in relation to factors that determine dialysis 
withdrawal. The primary objective of the study was to determine the rate of dialysis withdrawal 
and factors associated with dialysis withdrawal in chronic dialysis patients. The secondary 





Chapter 4 Methodology 
4.1 Study Design 
This retrospective study used structured and unstructured clinical data to extract the relevant 
information from hospital data sources. The study explored the factors associated with dialysis 
withdrawal in chronic dialysis patients, within the last five-year period (2012-2017) in Grand 
River Hospital, a large community hospital with a regional renal program in the region of 
Waterloo, Ontario, Canada.  
4.2 Study Sample 
4.2.1 Inclusion criteria 
The study cohort included all adult patients (>18 years) who initiated chronic renal 
dialysis therapy and were registered in the Renal program at Grand River Hospital (GRH), 
Ontario, from 1st January, 2012 to 30th September, 2017. The dialysis duration of 30 days or 
more was considered as chronic renal dialysis. It was calculated by the time elapsed from the 
first date of dialysis either at home or in centre to the last date of dialysis.  
4.2.2 Exclusion criteria 
The study excluded patients with only one dialysis date or without any terminal event 




dialysis (< 30 days) and was discharged/recovered or withdrew, but was later enrolled for 
chronic dialysis (>30 days), was included in the study. For these patients, the first day of starting 
the chronic dialysis treatment (coded as modality change to “chronic dialysis” in Nephrocare™  
was counted as the first day of dialysis. In addition, patients who were coded as chronic dialysis 
patients prior to the study date were excluded, which is to ensure the study cohort is restricted to 
incident dialysis patients.  
4.2.3 Sampling technique 
All patients following the selection criteria were consecutively included during the study period. 
The selection bias was reduced by restrictive selection criteria.  
4.3 Study Setting 
Grand River Hospital is a regional health centre serving Region of Waterloo and 
surrounding communities. The renal program in GRH is one of the largest community renal 
programs in Ontario, providing services to Chronic Kidney Disease patients, residing in 
Waterloo Region and Wellington County. The GRH renal program has one main hospital (GRH) 
and 5 satellite sites.   
4.4 Ethics Approval 
The Tri-Hospital Research Ethics Board (THREB) and the University of Waterloo 
Human Research Ethics Committee approved the research project (THREB File # 2016-0619) 
along with the waiver of “the requirement to obtain patient informed consent”, approval form 





4.5 Data Extraction 
The data were extracted from Nephrocare™ (electronic patient record system for renal 
patient management) and clinical notes in ClinicalConnect™ System which contains lab reports 
and clinician reports. The person level data were aggregated and de-identified. All Personal 
Health Information (PHI) protection measures during the data collection were implemented by 
ensuring appropriate access control to datasets and the crosswalk file.  All data was stored only 
on GRH managed computers on GRH secure network. Each patient was identified by a randomly 
generated Subject Identification Number (Subject_ID).  A crosswalk file containing the mapping 
between a Subject_ID and a patient’s Medical Record Number (MRN) was stored on a secure 
computer in GRH. 
The extracted data were entered in the excel sheet. The automatically extracted data were 
validated by randomly selecting the participants and comparing variable values with source data 
hosted in Nephrocare® and ClinicalConnect™. The missing values from automatically extracted 
dataset were completed by careful chart review by two graduate students with formal medical 
training.    
4.5.1 Steps of Data Collection 
Firstly, the data for the selected variables were extracted from Nephroport® and 
Nephrocare® during February 2017 to May 2017. The descriptive analysis was computed for 
validation and completeness of the data. The second stage was to review each patient’s record for 




selected variables were recorded in excel by the two graduate students. A number of patients 
were randomly selected and their medical record were reviewed for validation and quality of data 
entry by the two students. The third step was to complete the missing values. ClinicalConnect™ 
was used to review clinical notes and patients report files by the three graduate students. Each 
patient has several clinical notes and assessments summary (reports) and the logic for identifying 
most relevant reports include the selection of reports near the start of the dialysis, referral letter, 
nephrologist assessments, discharge reports, and anaesthesiologist reports.  
When reviewing clinical notes, if a diagnosis was found in relevant notes, that diagnosis 
was recorded in dataset, whereas a diagnosis was not explicitly mentioned in any reports, then 
the complete sentence relevant to diagnosis was recorded. This sentence was later classified into 
appropriate diagnosis by the two graduate students with medical background. For comorbidities, 
if there was any report of a diagnosis by the clinician at the start of dialysis, the patient was 
considered as having the said comorbidity, irrespective of subsequent recovery or improvement 
in condition of that disease.  
4.6 Study Variables 
The dependent variable was dialysis withdrawal (DW), which is defined as “elected-
dialysis withdrawal: patient voluntarily refused dialysis treatment and withdrew from the dialysis 
program”. Grand River Hospital’s protocol for handing DW requires a patient or his/her 
caregiver to present the request, followed by the nephrologist’s consultation and confirmation, 
and the necessary arrangement for the palliative care services. A patient who failed to come to 





The independent variables were: 
1) Age was estimated from the birth year till the date of collection of data, in years. 
2) Sex was coded as (Male=1/Female=2) 
3) Primary Renal Disease was categorized and coded as (Diabetes =1; Renovascular disease 
= 2; Other = 3; Nephritis = 4, and Unknown = 5). 
4) Comorbidity included following diseases and was coded as (Yes=1/No=2). All the 
comorbidities were diagnosed at the time of dialysis initiation. 
i. Diabetes (Yes=1/No=0) 
ii. Cardiac disease: Included Coronary Artery Disease (CAD), cardiac arrhythmia, 
cardiac failure, cardiac valvular disease, pericardial disease, cardiomyopathy, and 
congenital heart disease. It was coded as (Yes=1/No=0) 
iii. Vascular Accident: Included cerebrovascular accident such as stroke. 
iv. Hypertension (Yes=1/No=0) 
v. Malignancy (Yes=1/No=0) 
vi. Malignancy (Yes=1/No=0) 
vii. Depression (Yes=1/No=0) 
viii. Dementia (Yes=1/No=0) 
ix. Bipolar disorder (Yes=1/No=0) 
5) Modality: It was defined as the modality used 90 days after the first dialysis: 




6) Duration of dialysis: It was measured from the first day of chronic dialysis to the last day 
of dialysis or any terminal event such as withdrawal, death, transplant, or lost to follow 
up. 
4.7 Sample Size 
The sample size was calculated based on the work of Peduzzi et al. (1996) (57). 




where 𝑁 is the (minimum) required sample size, 𝑘 is the number of independent variables 
in the study, and 𝑝 is the smallest proportion of withdrawal patients in the population. In our study, 
given 𝑝 = 0.10 (9,10) based on literature and preliminary analysis, and 𝑘 =  7, the minimum 
required sample size is N=700.  
Bayesian Information Criterion (BIC) was used to determine the reliability value (the 
model selected by BIC being the model considered as being closest to the true model of the 
observed data) with (N=723) patients (58). The minimum reliability with (N= 723, d=7) in this 
study was 86%; where d=p (total predictors=14)-p*(maximum predictors to be included, 
calculated from sample size estimation) (57).  
4.8 Data Analysis 
All the data were analyzed by using SAS® studio University Edition. The descriptive data 




binary logistic regression was used to assess determinants of DW with duration of dialysis as 
confounder. 
For binary outcome, we are actually regressing the “tendency” of Y=1 (probability of subject 
withdrawing from dialysis) on X as follows: 
𝜂𝑖 = 𝛽0 + 𝛽1𝑋1𝑖 + ⋯ + 𝛽𝑘𝑋𝑘𝑖       ;      Subject 𝑖 = 1, ⋯ , 𝑛;  𝑘 = 14; 
where 
𝜂𝑖 = log (
𝑃𝑖
1−𝑃𝑖
), i.e., the log-odds of 𝑖th subject 
where, 
η = “eta” is the log-odds of patients who withdrew from dialysis. 
βi(i=0, 14) is the fixed regression coefficient denoting the effect of the corresponding 
predictor for the intercept including age, sex, modality, diabetes, vascular accident, cardiac 
disease, hypertension, malignancy, lung disease, dementia, depression, bipolar disorder, mental 
health, primary renal disease, and duration of dialysis, respectively. These variables are used as 





Chapter 5 Results 
5.1 Descriptive Results for Chronic Dialysis Population 
The sample size of the study was (N=723) chronic dialysis patients. The mean age of the 
sample was 64.86 (±14.89) years with minimum and maximum values of 19 and 94 years, 
respectively. Majority (54.1%) of the patients were between 40 to 60 years of age. There were 
62.6% (n=453) males. The most common cause of renal disease in the sample was diabetes 
(33.6%) and the most common comorbidity was hypertension (94.5%). The mean duration of 
dialysis was 544.80 days (±486.83) with minimum and maximum values of 30 and 2009 days. 
Majority of the patients have a duration of dialysis less than one year. The description of the 
patient characteristics is provided in Table 2 in detail. 
5.2 Descriptive statistics for Withdrawal 
The results showed that out of (N=723) chronic dialysis patients, 9.41% (n=68) patients 
have dialysis withdrawal. Majority of the DW patients were males (66.18%) with a mean age of 
71.72 (±13.90) years. The mean duration of dialysis within DW group was 411.88 (±466.06) 






Table 2 Descriptive Summary of Characteristics of Study Sample 
Variable Summary Statistics 




























Comorbidities n (%) 
          Diabetes 
 
461 (63.8) 
Infarct                          198 (27.4) 
Heart Disease                          413 (57.1) 
Vascular accident                          196 (27.1) 
Malignancy                          228 (31.5) 
Lung disease                          172 (23.8) 
Hypertension                          642 (88.8) 
Mental health                          232 (32.1) 
Depression                          213 (29.5) 
Dementia                          40 (5.5) 
Bipolar disorder                          18 (2.5) 






Duration of Dialysis in years n (%) 
          ≤1 
          ≤2 
          ≤3 
          ≤4 













Table 3 Descriptive Summary Characteristics in Dialysis Withdrawal Group 
Variable  Summary Statistics 





























Diabetes 41 (60.3) 
Infarct 23 (33.8) 
Heart Disease 48 (70.6) 
Vascular accident 26 (38.2) 
Malignancy 27 (39.7) 
Lung disease 22 (32.4) 
Hypertension 65 (95.6) 
Mental health 25 (36.8) 
Depression 19 (27.9) 
Dementia 9 (13.2) 
Bipolar disorder 2 (2.9) 























5.3 Reasons for Dialysis Withdrawal 
The results showed that the most common reason of dialysis withdrawal was non specific 
cause (51.47%), followed by psychosocial (23.5%) and palliative treatment (10.29%). The 
reasons for dialysis withdrawal are provided in Table 4 Reasons for Dialysis Withdrawal. 
Table 4 Reasons for Dialysis Withdrawal 
Reason n (%) 
Psychosocial  16 (23.5) 
Cancer 7 (10.29) 
Palliative 4 (5.88) 
Heart disease 2 (2.94) 
Pain 1 (1.47) 
Chronic illness 1 (1.47) 
Infection 1 (1.47) 
COPD 1 (1.47) 
Others: Non specific 35 (51.47) 











5.4 Logistic Regression Results 
5.4.1 Individual Model 
The logistic regression was performed for each predictor and confounder (duration of 
dialysis) with dialysis withdrawal to identify significant predictors that can be included in the 
final logistic regression models. For this approach, p value (level of significance) of 0.2 was 
considered as significant. The results showed that all predictors were significantly associated 
with dialysis withdrawal except for sex, kidney disease, diabetes, depression and bipolar 
disorder. The individual predictors and coefficients (β) are provided in Table 5. 
5.4.2 Combined Models 
For data analysis seven logistic regression models (Model A to G) were developed using 
different predictors and confounder. These models were developed to explore the associations 
between different set of predictors with dialysis withdrawal and to identify the model that can 
comment on the association between predictors and dialysis withdrawal based on literature, 





Table 5 Logistic Regression Results for Individual Predictors 
Variables  β (coefficient); p values 
Age 0.040; 0.0002* 
Sex -0.072; 0.59 
Kidney Disease Nephritis (0.109; 0.675),  
diabetes(-0.086; 0.700),  
other (-0.216; 0.381),  
renovascular disease (0.231; 0.434). 
Diabetes 0.045; 0.730 
Hypertension -0.872; 0.017* 
Malignancy -0.220; 0.095* 
Lung Disease -0.237; 0.085* 
Depression 0.012; 0.931 
Dementia -0.688; 0.0005* 
Bipolar Disorder -0.058; 0.879 
Vascular Accident -0.338; 0.012* 
Modality 0.441; 0.019* 
Cardiac Disease -0.404; 0.002* 
Duration of dialysis -0.0007; 0.017* 





Model “A” included all predictors (irrespective of statistical significance) and showed 
that age, cardiac disease, hypertension and dementia and duration of dialysis as a confounder 
were significantly associated with dialysis withdrawal, Model “B” included all significant 
predictors (except mental health component: dementia) and showed that age, hypertension and 
duration of dialysis (confounder) were significantly associated with dialysis withdrawal. Model 
“C” included all statistically significant predictors and showed that age, cardiac disease, 
hypertension, dementia and duration of dialysis (confounder) were significantly associated with 
dialysis withdrawal.  
Model “D” included the most relevant seven clinical predictors (irrespective of 
significance) and showed that age, hypertension and cardiac disease and duration of dialysis as 
confounder were significantly associated with dialysis withdrawal. Model “E” included all 
clinical significant predictors and showed that age, cardiac disease, hypertension and dementia 
and duration of dialysis (confounder) were significantly associated with dialysis withdrawal. 
Model “F” as shown in Table 6 was based on BIC (Bayesian Information Criterion) model 
selection, an algorithmic based selection of model. BIC provides a way to choose among 
different models with different numbers of variables by BIC scores. For this model, all predictors 
we included for model selection by BIC and the models with the lower BIC values are preferred. 
The model including variables of age, duration of dialysis, hypertension and dementia was 
preferred, based on BIB scores. This finding was similar to all the above models “A-E” except 





Table 6 BIC Model “F”  
Obs CandModel BIC scores 
1 Age      HTN 444.722 
2 Age      DD     HTN 445.248 
3 Age 445.858 
4 Age      DD      HTN      DE 448.589 
5 Age      DD 448.603 
Note. HTN=Hypertension, DD= Duration of dialysis, DE=Dementia 
 
5.5 Selection of Final Model 
The results from models “A-F” showed that predictors age, cardiac disease, hypertension 
and dementia were significantly associated with dialysis withdrawal, with significant influence 
of duration of dialysis on the above relationship. This finding indicates that the above predictors 
have a significant influence on dialysis withdrawal, irrespective of the number and type of 
variables selected within a model. The model parameter SAS outputs of all models “A-G” are 
provided as Appendix B. 
Based on the above models, sample size estimation (maximum number of predictors that 
can be included in the model) and the clinical and statistical significance of individual variables, 
model “G” was constructed as final model with age, modality, diabetes, cardiac disease, 
hypertension and dementia as predictors and duration of dialysis as confounders. To reiterate, 
that final model “G” was selected based on clinical and statistical significance and model “F” 




selecting almost similar set of variables. Hence, supporting the model based on clinical 
understanding and logic. The logistic regression parameters for individual predictors with 






Table 7 Logistic Regression parameter estimates for Individual and combined models “A-G” 
Variable Individual: β 
(coefficient); 
p values 
Model A: β 
(coefficient); 
p values 
Model B: β 
(coefficient)
; p values 
Model C: β 
(coefficient)
; p values 
Model D: β 
(coefficient)
; p values 
Model E: β 
(coefficient)
; p values 
Model F: β 
(coefficient)
; p values 



















Sex 0.072; 0.59 0.0962; 
0.7360 
  0.1524; 
0.5850 
   
Kidney Nephritis= -
0.109; 0.675,  
 
diabetes=0.08


















      
Diabetes -0.045; 0.730 -0.4223; 
0.2104 
























    













































Depress. -0.012; 0.931 -0.1441; 
0.6473 
      
Bipolar 0.058; 0.879 0.8351; 
0.3207 































Note. Kidney=Kidney Disease, Cardiac=Cardiac Disease, Vascular=Vascular Accident, Cancer=Malignancy, Hypert=Hypertension, 





5.5.1 Final Model Results and Interpretation 
The final model is shown in Table 8 with model estimates and odds ratios of the 
predictors. The results indicated that cardiac disease [=0.6530; p=0.016], hypertension 
[=1.7421; p=0.019], dementia [=1.1125; p=0.008] and age [=0.0342; p=0.002] were 
significantly associated with dialysis withdrawal. Hemodialysis and diabetes were not 
associated with dialysis withdrawal. The results also suggested that duration of dialysis 
[= - 0.000841; p=0.0092] significantly influence the above relationship between the 
predictors and dialysis withdrawal.  
From the odds ratio estimates shown in the above table, following can be 
interpreted from the model: 
1) The odds of dialysis withdrawal in patients with cardiac disease was 1.921 
[95% CI= 1.126-3.278] times vs patients without cardiac disease, with other 
variables held constant. 
2) The odds of dialysis withdrawal in patients with hypertension was 5.711 
[95% CI= 1.322-24.676] times vs patients without hypertension, with other 
variables held constant. 
3) The odds of dialysis withdrawal in patients with dementia was 3.042 [95% 
CI= 1.325-6.983] times vs patients without dementia, with other variables 
held constant. 
4) One-unit increase of duration, decreases the odds of dialysis withdrawal by a 




5) One-unit increase of age, increases the odds of dialysis withdrawal by a 
factor of 1.035 [95% CI=1.012 – 1.058] with other variables held constant.  
Table 8 Final Logistic Regression Model  
Parameter  SE  p AOR 95% CI AOR 
Intercept -6.2350 1.1468 <.0001   
Duration of 
dialysis 
-0.00084 0.000323 0.0092 0.999 0.999 - 1.00 
Modality    
HD vs PD (Ref) 
0.2986 0.3857 0.4388 1.348 0.633 – 2.870 
Age 0.0342 0.0113 0.0024 1.035 1.012 – 1.058 
Diabetes  Yes vs 
No(Ref) 
-0.4161 0.2790 0.1359 0.660 0.382 – 1.140 
Cardiac Disease  
Yes vs No(Ref) 
0.6530 0.2725 0.0166 1.921 1.126 – 3.278 
Hypertension 
Yes vs No(Ref) 
1.7424 0.7467 0.0196 5.711 1.322 – 24.676 
Dementia 
Yes vs No(Ref) 
1.1125 0.4240 0.0087 3.042 1.325 – 6.983 
Note. B=Estimate, SE B=Standard Error of Estimate, *p>0.05 as significant, AOR=Adjusted 
Odds Ratio, 95% CI AOR= 95% Confidence Interval for Adjusted Odds Ratio, 





Chapter: 6 Discussion 
Dialysis withdrawal is a common outcome in dialysis patients and authors in previous 
studies have explored the association with dialysis withdrawal. Despite the higher prevalence of 
dialysis withdrawal and its significant association with death in ESRD patients, the phenomenon 
of dialysis withdrawal remains unclear (59). The main reason is the inconsistency in defining 
dialysis withdrawal and scarcity of available literature (59). Authors have used different 
definitions to define dialysis withdrawal such as either withholding of dialysis, death, any reason 
for discontinuation, treatment refusal by patients and caregivers, or multiple combinations of 
these reasons. This study defined dialysis withdrawal as “patient refused further treatment or 
voluntary withdrawal from the dialysis program confirmed by patient consultation with 
nephrologist and coordinator”.  
The study results showed that only 9.41% (n=68) patients have dialysis withdrawal in the 
Regional Renal Program at the Grand River Hospital. The most common reason for dialysis 
withdrawal was psychosocial, followed by cancer. The study results also indicated that cardiac 
disease, hypertension, dementia and age were significantly associated with dialysis withdrawal, 
with significant influence of duration of dialysis (as a confounder) on the above relationship.  
6.1 Dialysis Withdrawal 
In this study, out of (N=723) chronic dialysis patients, 9.41% (n=68) patients had dialysis 
withdrawal during the period of this study. Previous studies have shown a DW rate ranging from 




patients in US, found 24.9% of the patients have dialysis withdrawal (9). Mizuno (2011) 
conducted a retrospective study in Japan and found dialysis attrition was 31% (11). Chan et al. 
(2012) found incidence dialysis withdrawal of 3.5% and 13.4% for one and five years, 
respectively (10). The reason for this wide range of reported rate of dialysis withdrawal may be 
related to the inconsistent definition of dialysis withdrawal used in these studies.  
6.2 Factors Associated with Dialysis Withdrawal: 
The results in this study showed that cardiac disease [= 0.6530; p=0.016], 
hypertension [= 1.7421; p=0.019], dementia [=1.1125; p=0.008] and age [=0.0342; 
p=0.002] were significantly associated with dialysis withdrawal. Comorbidities such as 
diabetes, hypertension, cardiac disease are chronic diseases, gradually deteriorate patient health 
status, leading to complications that initiate a cascade of health issues (42). These health issues 
increase the burden of disease and lead patients to discontinue dialysis treatment. This study 
showed that among the selected comorbidities, only cardiac disease, hypertension and dementia 
can lead to dialysis withdrawal, highlighting the importance of these factors in chronic dialysis 
population.  
Birmele et al. (2004) found dementia was significantly associated with dialysis 
withdrawal, but other comorbidities including cardiovascular disease were not associated 
with dialysis withdrawal (13). Ellwood et al. (2013) and Fissell et al. (2005) also found that 
vascular diseases and coronary artery disease were positively associated with dialysis 
withdrawal, but congestive heart failure was not associated with dialysis withdrawal (11, 
18). The differences between the results in the present study with the above two studies 




withdrawal as “patient-elected withdrawal” vs. dialysis discontinuation due to any reason 
except for discontinuation of dialysis due to recovery of kidney functions (Ellwood et al. 
2013) and unspecified dialysis termination including Do Not Resuscitate (DNR) patients 
and death (Fissell et al., 2005) (11, 18). 
Wetmore et al. (2017) recently conducted a study defining dialysis withdrawal as 
“patient and family elected discontinuation of dialysis” found that atherosclerotic heart 
disease (OR, 0.91; 95% CI 0.88-0.95), hypertension (OR, 1.05; 95% CI 1.00-1.10) 
arrhythmia (OR, 1.25; 95% CI 1.20-1.29) and other cardiac disease (OR, 1.12; 95% CI 
1.08-1.16) are more likely to have dialysis withdrawal, similar to the present study (60). 
However, Wetmore et al. (2017) did not explore mental health component (dementia, 
depression and bipolar disorder) in contrast to present study (60). Physical health 
components such as cardiac and vascular disease, diabetes, infection, cerebrovascular 
disease, stroke, malignancy, and lung disease have been explored by several authors in 
relation to dialysis withdrawal, but mental health components such as depression/anxiety 
and dementia have been rarely explored (9-16, 60). Kurella et al. (2006) found dementia 
was associated with increased risk of death and dialysis withdrawal (61). However, 
definition of dialysis withdrawal was not clear in the above study.   
Mental health conditions such as depression have been associated with poor psychosocial 
outcomes, decrease quality of life, adverse medical outcomes such as worsening of kidney 
functions and death in ESRD patients (62). Similarly, authors have also found significant 
association between dementia with comorbidities such as cardiac disease, myocardial infarction, 
cerebrovascular disease, stroke, diabetes, cancer and quality of life (63-65). This relationship 




kidney disease is complex (62). Patients with comorbidities have a higher risk of mental health 
issues than patients without comorbidities (17, 54). Similarly, patients with mental conditions 
such as depressive symptoms and dementia have higher incidence of comorbidities (62). Because 
of this bidirectional relationship it is difficult to distinguish and understand the biologic 
plausibility between the comorbid conditions and mental health issues in relation to dialysis 
withdrawal. This association between comorbid conditions and quality of life with dementia may 
be the reason of higher odds of dialysis withdrawal in patients with dementia, as found in the 
present study. 
The present study showed that age was significantly associated with dialysis 
withdrawal that is increase in age increases the odds of dialysis withdrawal. Authors have 
shown that older age was associated with higher rate of dialysis withdrawal, similar to our 
findings (10, 11, 37). Ellwood et al. (2013) found that increasing age was significantly associated 
with dialysis withdrawal (HR, 1.81; 95% CI 1.75–1.88) (11). Wetmore et al. (2017) define 
dialysis withdrawal as “patient and family elected discontinuation of dialysis”, similar to the 
present study and showed higher odds of withdrawal in dialysis patients with age > 75 years 
(OR,1.61; 95% CI 1.54-1.68) (60).  
Moreover, the relationship between age and dialysis withdrawal is complex. Older age 
patients have multiple comorbidities that are difficult to control such as diabetes and 
hypertension that further debilitates with dialysis, leading to drastic deteriorations in physical 
and mental health and perhaps resulting in dialysis withdrawal (11, 13, 38). However, older 
people need more social and emotional support, visiting dialysis centre, meeting nursing staff 
who provide care for them and with whom they can interact and communicate their problems 




and enhancing adaptability, but also supporting decision making, and providing emotional 
support and education during dialysis, resulting in promoting the positive attitude to continuation 
of dialysis within these patients (68).  
This study did not find any association between sex, dialysis modality (HD or PD), 
comorbidities such as diabetes, vascular accident, lung disease, malignancy, depression and 
bipolar disorder, and cause of kidney disease in different models (models A to G logistic 
regression models), though many of these variables were significant at individual levels 
(regression models for each predictor and total duration). Authors have shown inconsistent 
findings between the above variables such as sex, dialysis modality and comorbidities with 
dialysis withdrawal. Males have negative association (10, 11), females have positive 
association (59) and sex have no association with dialysis withdrawal (15, 69). 
There were inconsistent findings in studies on the association between type of 
modality and DW. For instance, PD was found negatively associated (Chan et al., 2012) 
with dialysis withdrawal; whereas Ellwood et al. (2013) and Birmele et al. (2004) found 
insignificant influence of modality type on dialysis withdrawal.  This study also found no 
association between modality type and DW similar Ellwood et al (2013) and Birmele et al 
(2004) findings. The inconsistent study findings may be caused by how the modality type 
was defined in these studies, as many of the patients on PD will eventually have to switch 
to HD due to complications.  
Authors have reported that diabetes and hypertension as aetiology of ESRD were 
significantly associated with dialysis withdrawal, in contrast to findings of the present 




cerebrovascular disease, COPD and malignancy have been associated with dialysis 
withdrawal, in contrast to insignificant findings reported in this study (9, 10, 60). There are 
several reasons for the above difference in findings. Firstly, the study selected several 
comorbidity predictors to explore these associations. Initial logistic models (model A and 
B) included all predictors and showed insignificant association, may be because of 
insufficient sample size (Type II error). A priori sample size calculation revealed that 
maximum of seven variables should be included in the model to minimize type II error (false 
negative) in this study. Therefore, the final model did not include variables such as lung 
disease, malignancy, vascular accident, depression and bipolar disorder, based on clinical 
and statistical significance and to minimize type II error.  
Secondly, dialysis (both HD and PD) have few absolute and relative contraindications 
including severe cardiovascular instability such as severe hypotension, cardiac insufficiency, 
arrhythmias, and myocardial infarction, intracranial hemorrhage, advanced stage malignancy, 
uncontrolled serious diabetes, severe bleeding tendency and severe mental problems. The 
chronic dialysis patients in this study were expected to have already been screened for the 
contraindications, such as the severity of these diseases and disorders before starting dialysis. 
Patients with diabetes, malignancy, dementia, depression, bipolar disorder, stroke, vascular 
accidents have mild to moderate severity of these diseases, not significant enough for these 
patients to have dialysis withdrawal in this study. Patients with better health status at the start of 
dialysis have a lower risk of dialysis withdrawal than patients with poor health status (42).  
Thirdly, the predictors were measured at the start of dialysis. Many of these 
comorbidities are not constant and are dependent on several factors such as duration of disease, 




these factors, progress and control of these comorbidities due to limitations of retrospective data 
collection. It may be that patients with diabetes have well controlled blood sugar levels, patients 
with stroke have mild complications, lung disease patients have mild to moderate COPD, 
depression patients have been controlled and may be cured by medications, reducing the odds of 
withdrawal in these patients, in the present study. 
Finally, the aforementioned relationship between predictors and dialysis withdrawal is 
significantly confounded (p<0.05) by duration of dialysis. Duration of dialysis may influence 
relationship between comorbidity and dialysis withdrawal, as chronic diseases gradually 
deteriorate patient health status over time, leading to complications that initiate a cascade of 
health issues. These health issues increase the burden of disease and lead patients to discontinue 
dialysis treatment (42). Wetmore et al. (2017) have shown higher odds of withdrawal in patients 
with higher duration of dialysis vs lower duration (60). However, the odds of withdrawal in this 
study was just 0.999 [95% CI 0.999-1.00], (close to 1) and hence not clinically meaningful. The 
reason may be that most of the patients have lower duration of dialysis, as the analysis was 
restricted to last 5 years only including incident dialysis patients. Patients with start of dialysis 
prior to start of the study period and more than 5 years of dialysis were not captured in the study, 
though patients with more than 5 years of dialysis duration are less frequently observed in 
clinical practice.  
The study also identified reasons of dialysis withdrawal. The most common reason was 
psychosocial (23.5%), followed by cancer (10.29&), palliative care (5.88%), heart disease 
(2.44%) and pain, infection, chronic illness and COPD (1.47% for each); while for 51.47% of the 
patients there was no specific reason.  Considering the small sample and number of reasons for 




most common reason among other physical comorbidities such as COPD, infection and chronic 
illness supplements the study findings in regards to importance of mental health disorders such 
as dementia vs. physical comorbidities such as malignancy, lung disease and vascular accidents 
in dialysis withdrawal.  
DeVelasco & Dinwiddie (1998) found that one of the common reason for dialysis 
withdrawal was dementia (70). In addition, societal reasons also have significant influence 
related dialysis withdrawal (46). Workeneh et al. (2015) found lack of support as one of the main 
reasons for dialysis withdrawal (16%) (14). However, Cohen et al. (2000) found common 
reasons for dialysis withdrawal include chronic disease deterioration, acute intercurrent disorder, 
technical problems of dialysis and failure to thrive (71). The difference in findings in this study 
may be attributed to small sub sample of dialysis withdrawal and because of > 50% of the 
dialysis withdrawal patients with no specific cause. Future research is needed to identify the 
patient-reported reasons for dialysis withdrawal and the factors related to these reasons, to make 
further inferences.  
6.3 Strengths 
1) The strengths of the current study include the exploration of a large sample data 
spanning, last five years and a priori calculated sample size to minimize type II errors. 
2) Validity of the data from multiple data sources including Nephrocare™ and 
ClinicalConnect™. Furthermore, the extracted data was validated by two graduate 




3) Strict inclusion criteria to reduce selection bias, only including incidental chronic dialysis 
patients. 
4) Clearly defined “withdrawal” as patients-elected dialysis withdrawal, conformed to GRH 
withdrawal protocol, not include those patients stopped treatment because of a return of 
kidney function, nor withholding treatment due to imminent death.  
5) Consecutive sampling, all participants following the selection criteria within the study 
period were included, improves the generalizability of the sample. 
6.4 Limitations 
1. The main weakness of the study is the retrospective study design, which depends entirely 
on the quality and completeness of the patient records.  The quality of the dataset for this 
study was also dependent on the data quality of clinician notes and data entry of the 
electronic patient record systems. However, careful review of randomly selected patient 
records provided limited level of assessment of the accuracy between the extracted data 
with source system of patient records. 
2. Another limitation of a retrospective study was the limitation on variable section for the 
study.  Not all comorbid conditions were recorded reliably in the patient chart, although 
most of the relevant variables identified in the literature review were documented in 
Nephrocare® by the renal coordinators.  The most problematic variables in 
documentation, are the psychosocial factors such as, depression, income and quality of 




3. The study wasn’t able to explore the relation between financial burden, beliefs, cultural 
and personal and to the decision to withdrawal the treatment either by family or 
individual.  These topics were beyond the scope of the current study yet are highly 
relevant for determining the factors that influence DW. 
4. Being a single center study the generalizability of the study was limited, but consecutive 
sampling was performed to make a sample better representation of the target population.  
5. Selection and misclassification bias was common in retrospective studies. However, 
stringent inclusion and exclusion criteria for chronic dialysis patients were applied and 
clear and measurable outcome were defined, especially the withdrawal definition, which 
reduced selection and misclassification bias, respectively. 
6.5 Advancement of Knowledge and Application in Practice: Implications 
of the Study  
The study showed a low rate of dialysis withdrawal (9.41%) and age, cardiac disease, 
hypertension and dementia as significant predictors related to dialysis withdrawal among dialysis 
patients managed by the GRH Renal Program. This finding highlighted that the presence of 
cardiac disease, hypertension and dementia can increase odds of dialysis withdrawal.  
The findings may help developing a screening instrument taking into consideration of the 
predictors identified in the study such as cardiac disease, hypertension, and dementia.  This 
screening instrument can be used to identify patients with higher risk of dialysis withdrawal at 
the time of enrolment in chronic dialysis program. This instrument may help clinical decision 




have a better control of these comorbidities at the dialysis initiation and throughout the entire 
treatment. 
The findings will also help in identifying possible patient specific barriers and issues so 
early intervention strategies can be developed and applied. Some of these strategies may be 
frequent patient follow up and treatment, and management care for severity assessment and 
progression and control of these comorbidities, so as to reduce their risk of dialysis withdrawal in 
future. 
One of the most important finding was identification of mental health component, in 
particular, dementia as one of the factors associated with dialysis withdrawal.  Lack of social 
support and mental health are known to be one of the main barriers of the continuity of dialysis.  
These two components are highly interrelated, since lack of social support has a negative 
influence on mental health. However, due to the limited sample size and the quality of relevant 
data contained in patient charts, we did not explore these topics in depth.  
Most dialysis program screened patients for severe mental health issues prior to the 
enrollment of the dialysis program, and often will exclude patients with severe mental health 
conditions. This study identified a need for a modified mental health screening instrument 
specific for dialysis patients, and the need for continuous monitoring of patients’ mental health. 
Due to its cross-sectional nature, this study was unable to comment on the causal association 
between mental health and dialysis withdrawal.  
The ROC (Receiving Operator Curves) for prediction of DW, while using different set of 
predictors for models “A-G” were evaluated as shown in appendix B, though predictive 




prediction models for DW, based on different predictors, to identify variables with the highest 
level of probability and sensitivity and specificity.  
6.6 Conclusions 
The study showed a low rate of dialysis withdrawal (9.41%) in a cohort (N=723) of 
chronic dialysis patients included in the study. The most common reason for dialysis withdrawal 
was psychosocial 16 (23.5%) while 35 (51.47%) of the patients didn’t have any specific reason 
for dialysis withdrawal. Age, cardiac disease, hypertension and dementia were associated with 
dialysis withdrawal, with significant influence of duration of dialysis (as a confounder) on the 
above relationship in chronic dialysis population. These findings may help in identifying a 
cohort of patients that are susceptible to dialysis withdrawal at the start of dialysis.  
Based on the findings of this study, the following future studies could be designed and 
conducted:  
1. Design and conduct intervention studies focusing on controlling the severity of 
comorbidities (cardiac disease, hypertension and dementia) by frequent follow up of 
patients  
2. Qualitative study designed to understand the reason for withdrawal including belief, 
cultural and life style choices on withdrawal 
3. Assessment for mental health disorders to better monitor patient’s onset and 
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